Circulating Maternal Serum Cell Free Fetal DNA Levels for Prediction of Preeclampsia

Abstract Objective To measure the maternal serum cell free fetal DNA and establish the relationship between maternal serum cell free fetal DNA levels and preeclampsia (PE). Study Design A nested case-control study was conducted on 30 patients with PE and 30 matched controls aged (18-40 years) attend...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:QJM : An International Journal of Medicine 2024-10, Vol.117 (Supplement_2)
Hauptverfasser: Mohamed Ibrahim, Mohamed El Mandouh, Bahaa El Din, Ahmed Mohamed, Mohamed Nassar, Salma Ashraf, Mohamed Helmy, Mohamed Mahmoud
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title QJM : An International Journal of Medicine
container_volume 117
creator Mohamed Ibrahim, Mohamed El Mandouh
Bahaa El Din, Ahmed Mohamed
Mohamed Nassar, Salma Ashraf
Mohamed Helmy, Mohamed Mahmoud
description Abstract Objective To measure the maternal serum cell free fetal DNA and establish the relationship between maternal serum cell free fetal DNA levels and preeclampsia (PE). Study Design A nested case-control study was conducted on 30 patients with PE and 30 matched controls aged (18-40 years) attending Ain Shams university maternity hospital, with single viable fetus beyond 20 weeks gestational age. Blood samples were withdrawn upon enrollment; then measuring the cell free fetal DNA was done upon identification of cases and matched controls. Results The study showed that there was a significant difference in CFFDNA level between the studied groups, with patients with preeclampsia having higher levels than controls. Also, the maternal serum CFFDNA level can accurately predict preeclampsia, with area under the curve 0.979. Conclusion Maternal serum cell free DNA can be used for prediction of PE. The mean levels of CFFDNA correlate with probability of developing maternal complications in cases of PE.
doi_str_mv 10.1093/qjmed/hcae175.592
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_qjmed_hcae175_592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/qjmed/hcae175.592</oup_id><sourcerecordid>10.1093/qjmed/hcae175.592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c792-43c23e1e3a5e676fa20d85b8feeb0f42e7520cd95c56a154b99e0d01d623cc5d3</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRS0EEqXwAez8AaT1I07iZRUoIIWHRPaRY48hlfPATpD4e1Ja9qxm5uqeWRyErilZUSL5-nPXgll_aAU0FSsh2Qla0DghEeOSn_7tKRPn6CKEHSEkTuNsgcq88Xpyamy6d_ykRvCdcvgN_NTiHJzDWw-AtzDO6e3zBhfwBS5g23v86sE0emz6Dvd2f4F2qh1Coy7RmVUuwNVxLlG5vSvzh6h4uX_MN0WkU8mimGvGgQJXApI0sYoRk4k6swA1sTGDVDCijRRaJIqKuJYSiCHUJIxrLQxfInp4q30fggdbDb5plf-uKKn2VqpfK9XRSjVbmZmbA9NPwz_qP2XzZuI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Circulating Maternal Serum Cell Free Fetal DNA Levels for Prediction of Preeclampsia</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Mohamed Ibrahim, Mohamed El Mandouh ; Bahaa El Din, Ahmed Mohamed ; Mohamed Nassar, Salma Ashraf ; Mohamed Helmy, Mohamed Mahmoud</creator><creatorcontrib>Mohamed Ibrahim, Mohamed El Mandouh ; Bahaa El Din, Ahmed Mohamed ; Mohamed Nassar, Salma Ashraf ; Mohamed Helmy, Mohamed Mahmoud</creatorcontrib><description>Abstract Objective To measure the maternal serum cell free fetal DNA and establish the relationship between maternal serum cell free fetal DNA levels and preeclampsia (PE). Study Design A nested case-control study was conducted on 30 patients with PE and 30 matched controls aged (18-40 years) attending Ain Shams university maternity hospital, with single viable fetus beyond 20 weeks gestational age. Blood samples were withdrawn upon enrollment; then measuring the cell free fetal DNA was done upon identification of cases and matched controls. Results The study showed that there was a significant difference in CFFDNA level between the studied groups, with patients with preeclampsia having higher levels than controls. Also, the maternal serum CFFDNA level can accurately predict preeclampsia, with area under the curve 0.979. Conclusion Maternal serum cell free DNA can be used for prediction of PE. The mean levels of CFFDNA correlate with probability of developing maternal complications in cases of PE.</description><identifier>ISSN: 1460-2725</identifier><identifier>EISSN: 1460-2393</identifier><identifier>DOI: 10.1093/qjmed/hcae175.592</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>QJM : An International Journal of Medicine, 2024-10, Vol.117 (Supplement_2)</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Mohamed Ibrahim, Mohamed El Mandouh</creatorcontrib><creatorcontrib>Bahaa El Din, Ahmed Mohamed</creatorcontrib><creatorcontrib>Mohamed Nassar, Salma Ashraf</creatorcontrib><creatorcontrib>Mohamed Helmy, Mohamed Mahmoud</creatorcontrib><title>Circulating Maternal Serum Cell Free Fetal DNA Levels for Prediction of Preeclampsia</title><title>QJM : An International Journal of Medicine</title><description>Abstract Objective To measure the maternal serum cell free fetal DNA and establish the relationship between maternal serum cell free fetal DNA levels and preeclampsia (PE). Study Design A nested case-control study was conducted on 30 patients with PE and 30 matched controls aged (18-40 years) attending Ain Shams university maternity hospital, with single viable fetus beyond 20 weeks gestational age. Blood samples were withdrawn upon enrollment; then measuring the cell free fetal DNA was done upon identification of cases and matched controls. Results The study showed that there was a significant difference in CFFDNA level between the studied groups, with patients with preeclampsia having higher levels than controls. Also, the maternal serum CFFDNA level can accurately predict preeclampsia, with area under the curve 0.979. Conclusion Maternal serum cell free DNA can be used for prediction of PE. The mean levels of CFFDNA correlate with probability of developing maternal complications in cases of PE.</description><issn>1460-2725</issn><issn>1460-2393</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkMtOwzAQRS0EEqXwAez8AaT1I07iZRUoIIWHRPaRY48hlfPATpD4e1Ja9qxm5uqeWRyErilZUSL5-nPXgll_aAU0FSsh2Qla0DghEeOSn_7tKRPn6CKEHSEkTuNsgcq88Xpyamy6d_ykRvCdcvgN_NTiHJzDWw-AtzDO6e3zBhfwBS5g23v86sE0emz6Dvd2f4F2qh1Coy7RmVUuwNVxLlG5vSvzh6h4uX_MN0WkU8mimGvGgQJXApI0sYoRk4k6swA1sTGDVDCijRRaJIqKuJYSiCHUJIxrLQxfInp4q30fggdbDb5plf-uKKn2VqpfK9XRSjVbmZmbA9NPwz_qP2XzZuI</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Mohamed Ibrahim, Mohamed El Mandouh</creator><creator>Bahaa El Din, Ahmed Mohamed</creator><creator>Mohamed Nassar, Salma Ashraf</creator><creator>Mohamed Helmy, Mohamed Mahmoud</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20241001</creationdate><title>Circulating Maternal Serum Cell Free Fetal DNA Levels for Prediction of Preeclampsia</title><author>Mohamed Ibrahim, Mohamed El Mandouh ; Bahaa El Din, Ahmed Mohamed ; Mohamed Nassar, Salma Ashraf ; Mohamed Helmy, Mohamed Mahmoud</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c792-43c23e1e3a5e676fa20d85b8feeb0f42e7520cd95c56a154b99e0d01d623cc5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohamed Ibrahim, Mohamed El Mandouh</creatorcontrib><creatorcontrib>Bahaa El Din, Ahmed Mohamed</creatorcontrib><creatorcontrib>Mohamed Nassar, Salma Ashraf</creatorcontrib><creatorcontrib>Mohamed Helmy, Mohamed Mahmoud</creatorcontrib><collection>CrossRef</collection><jtitle>QJM : An International Journal of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohamed Ibrahim, Mohamed El Mandouh</au><au>Bahaa El Din, Ahmed Mohamed</au><au>Mohamed Nassar, Salma Ashraf</au><au>Mohamed Helmy, Mohamed Mahmoud</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating Maternal Serum Cell Free Fetal DNA Levels for Prediction of Preeclampsia</atitle><jtitle>QJM : An International Journal of Medicine</jtitle><date>2024-10-01</date><risdate>2024</risdate><volume>117</volume><issue>Supplement_2</issue><issn>1460-2725</issn><eissn>1460-2393</eissn><abstract>Abstract Objective To measure the maternal serum cell free fetal DNA and establish the relationship between maternal serum cell free fetal DNA levels and preeclampsia (PE). Study Design A nested case-control study was conducted on 30 patients with PE and 30 matched controls aged (18-40 years) attending Ain Shams university maternity hospital, with single viable fetus beyond 20 weeks gestational age. Blood samples were withdrawn upon enrollment; then measuring the cell free fetal DNA was done upon identification of cases and matched controls. Results The study showed that there was a significant difference in CFFDNA level between the studied groups, with patients with preeclampsia having higher levels than controls. Also, the maternal serum CFFDNA level can accurately predict preeclampsia, with area under the curve 0.979. Conclusion Maternal serum cell free DNA can be used for prediction of PE. The mean levels of CFFDNA correlate with probability of developing maternal complications in cases of PE.</abstract><pub>Oxford University Press</pub><doi>10.1093/qjmed/hcae175.592</doi></addata></record>
fulltext fulltext
identifier ISSN: 1460-2725
ispartof QJM : An International Journal of Medicine, 2024-10, Vol.117 (Supplement_2)
issn 1460-2725
1460-2393
language eng
recordid cdi_crossref_primary_10_1093_qjmed_hcae175_592
source Oxford University Press Journals All Titles (1996-Current)
title Circulating Maternal Serum Cell Free Fetal DNA Levels for Prediction of Preeclampsia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T16%3A10%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20Maternal%20Serum%20Cell%20Free%20Fetal%20DNA%20Levels%20for%20Prediction%20of%20Preeclampsia&rft.jtitle=QJM%20:%20An%20International%20Journal%20of%20Medicine&rft.au=Mohamed%20Ibrahim,%20Mohamed%20El%20Mandouh&rft.date=2024-10-01&rft.volume=117&rft.issue=Supplement_2&rft.issn=1460-2725&rft.eissn=1460-2393&rft_id=info:doi/10.1093/qjmed/hcae175.592&rft_dat=%3Coup_cross%3E10.1093/qjmed/hcae175.592%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/qjmed/hcae175.592&rfr_iscdi=true